Lauric Haber

11 Patents

• US125773042026

  Anti-cd3 Antibodies with Low Binding Affinity

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US125707642026

  Anti-muc16 Antibodies, Antibody-drug Conjugates, and Bispecific Antigen-binding Molecules That Bind MUC16 and CD3, and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US124418002025

  Bispecific Anti-psma X Anti-cd28 Antibodies and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US124158562025

  EGFR X CD28 Multispecific Antibodies

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US123446772025

  Anti-psma Antibodies, Bispecific Antigen-binding Molecules That Bind PSMA and CD3, and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US120776032024

  Multispecific Antigen-binding Molecules for Cell Targeting and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US120655082024

  Multispecific Antigen-binding Molecules for Cell Targeting and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US119524302024

  Multispecific Antigen-binding Molecules for Cell Targeting and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US119127672024

  EGFR × CD28 Multispecific Antibodies

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US116335012023

  Anti-steap2 Antibodies, Antibody-drug Conjugates, and Bispecific Antigen-binding Molecules That Bind STEAP2 and CD3, and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US115489472023

  Bispecific Anti-psma X Anti-cd28 Antibodies and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites